CMV is a ubiquitous pathogen with a global distribution. Seroprevalence rates vary widely depending on geographic location, socioeconomic status, and age. For example, in the United States, CMV seroprevalence ranges from 50% to 80% among adults, whereas in developing countries, it can be as high as 100%.
